In a subsequent step, they are absorbed into all cells via so-called passive diffusion

mean hair count increase 91.4 vs 22.2 new hairs Evidence Level: Level II (randomised controlled trial) PubMed: PMC3746236 Study 3: PDRN Polynucleotide Gel for Pattern Hair Loss Authors: Published in Archives of Dermatological Research , 2024 Journal: Arch Dermatol Res , 2024 Condition: Pattern hair loss (androgenetic alopecia) Treatment: PDRN (polydeoxyribonucleotide) polynucleotide gel, topical application Sample: Clinical trial with tolerability and satisfaction endpoints Key Result: PDRN polynucleotide gel significantly improved pattern hair loss with high tolerability and patient satisfaction scores Evidence Level: Level II-III (clinical trial) PubMed: 38842633 Study 4: GHK-Cu Microemulsion Accelerated Hair Growth Authors: Published in Pharmaceutics , 2024 Journal: Pharmaceutics , 2024 Condition: Hair follicle growth cycle regulation Treatment: GHK-Cu delivered via microemulsion formulation Sample: Preclinical study with follicle growth measurement Key Result: GHK-Cu microemulsion-treated follicles entered anagen growth phase in 6 days vs 9 days for conventional treatment 33% faster growth initiation Evidence Level: Level III (preclinical/in vitro) PubMed: PMC10643103 How to Cite This Page APA format: Smith, M

Refer to the vial label for lot-specific details
Some people also explore it as an off-label option for recovery support, skin and tissue maintenance, and general vitality
Chronic fatigue syndrome: acute infection and history of physical activity affect resting levels and response to exercise of plasma oxidant/antioxidant status and heat shock proteins